Pharmaceutical News

RSS

NIDA announces 2012 recipient of Avant-Garde Award for Medications Development

Dr. Gary R. Matyas has been selected the 2012 recipient of the NIDA Avant-Garde Award for Medications Development. Matyas proposes to develop an effective, safe and easily manufactured combination anti-heroin/HIV vaccine that could treat heroin addiction while at the same time prevent HIV infection in those receiving the vaccine.

26 Jul 2012

RADARS System Poison Center data can predict methadone overdose trends in the U.S.

A new report, published today in PLoS One shows that RADARS(R) System Poison Center data can be used to predict methadone overdose trends in the U.S.

26 Jul 2012

Excess maternal iodine supplementation can lead to congenital hypothyroidism in infants

Congenital hypothyroidism is thyroid hormone deficiency at birth that, if left untreated, can lead to neurocognitive impairments in infants and children. Although the World Health Organization recommends 200-300 -g of iodine daily during pregnancy for normal fetal thyroid hormone production and neurocognitive development, the US Institute of Medicine considers 1,100 -g to be the safe upper limit for daily ingestion.

26 Jul 2012

BD Hyflow needle essential for patient comfort and device integration

BD Medical, a segment of BD, today announced the launch of the BD Hyflow™ needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems.

From BD (Becton, Dickinson and Company) 26 Jul 2012

FDA grants priority review to GSK’s Promacta sNDA for treatment of thrombocytopenia

Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has been granted priority review from the US Food and Drug Administration for the supplemental new drug application for Promacta to treat thrombocytopenia in adult patients with chronic hepatitis C virus (HCV) infection.

26 Jul 2012

Fever in laboring women not associated with epidural analgesia

A study from the August issue of Anesthesiology provides evidence contrary to prior reports that fever in laboring women is associated with epidural analgesia.

26 Jul 2012

Study identifies 329 instances of potentially inappropriate prescribing in Irish older patients

Research published in the journal Age and Ageing, which studied nursing homes in the Munster region of Ireland, has found that a significant proportion of older patients have either been prescribed a potentially inappropriate medicine or they are not prescribed a medicine that would normally be beneficial.

26 Jul 2012

Recent release: More effort needed to reach universal access to ART by 2015, MSF/UNAIDS report says

"Much still needs to be done to get treatment to those who need it and to meet the UNAIDS-endorsed goal to achieve universal access by 2015, according to a new survey examining 25 HIV indicators assessing strategies, tools and policies to get the best HIV treatment to more people, sooner," the Center for Global Health Policy's "Science Speaks" blog reports.

26 Jul 2012

Drug resistance increasing in parts of Africa, report shows

"Resistance to AIDS drugs, a problem that has been widely feared over the last decade, is growing in parts of Africa but should not hamper the life-saving drug rollout, researchers reported on Monday" in a study published in the Lancet, Agence France-Presse reports.

25 Jul 2012

New NIAID grant to support development of topical microbicide gel for HIV and HSV-2 infections

A new grant from the National Institute of Allergy and Infectious Diseases (NIAID) will support the development of a topical microbicide gel for drug delivery. The innovative gel formulation will be a combination therapy against human immunodeficiency virus (HIV) and herpes simplex virus type 2 (HSV-2) infections in women.

25 Jul 2012

EC grants Marketing Authorisation to Boehringer Ingelheim and Lilly’s Jentadueto for diabetes

Boehringer Ingelheim and Eli Lilly and Company received Marketing Authorisation from the European Commission for Jentadueto which combines the DPP-4 inhibitor, linagliptin and metformin in a single tablet.

25 Jul 2012

EMA COMP issues positive opinion to Albireo for A4250

Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that the European Medicines Agency Committee for Orphan Medicinal Products (COMP) has issued a positive opinion on an application for orphan medicinal product status for the company's lead hepatology candidate, A4250.

25 Jul 2012

Aeterna Zentaris files request with FDA for Fast Track designation for AEZS-130

Aeterna Zentaris Inc. today announced that it has filed a request with the United States Food and Drug Administration (FDA) for Fast Track designation for its oral ghrelin agonist, AEZS-130, as a diagnostic test for adult growth hormone deficiency (AGHD).

25 Jul 2012

Merck, Chimerix sign license agreement for CMX157 to treat HIV infection

Chimerix, Inc. today announced the execution of a license agreement granting Merck, known as MSD outside the United States and Canada, exclusive worldwide rights to CMX157, Chimerix's novel lipid acyclic nucleoside phosphonate currently being evaluated to treat HIV infection.

24 Jul 2012

Biokine receives FDA Orphan Drug designation for BKT140 to treat hematological cancers

Biokine Therapeutics Ltd. announced today that it has received Orphan Drug designation from the US Food and Drug Administration (FDA) for the mobilization of hematopoietic stem cells from bone marrow into peripheral blood for collection and subsequent transplantation in patients with hematological cancers.

24 Jul 2012

Microneedles can deliver drug formulations into the eye

Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.

24 Jul 2012

FDA approves 152 antiretroviral drugs in association with PEPFAR to treat HIV/AIDS

Today, U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg announced the agency has approved or tentatively approved a total of 152 antiretroviral drugs in association with the President's Emergency Plan for AIDS Relief (PEPFAR) to treat those infected with HIV/AIDS in countries that lack the tools needed to fight the AIDS epidemic.

24 Jul 2012

Mephedrone does have potential for abuse and addiction

The use of the synthetic stimulants collectively known as "bath salts" have gained popularity among recreational drug users over the last five years, largely because they were readily available and unrestricted via the Internet and at convenience stores, and were virtually unregulated.

24 Jul 2012

New FDA guidelines on HIV And TB drug doses may not apply to African and Asian patients

In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.

24 Jul 2012

Cost of HIV drugs cost less than previous thought, Clinton Foundation study says

"Lack of money can no longer be considered a reason -- or an excuse -- for failing to treat all those with HIV who need drugs to stay alive, following game-changing work about to be published by the Clinton Foundation that shows the real cost is four times less than previously thought," the Guardian reports.

24 Jul 2012

Pharmaceutical News

NIDA announces 2012 recipient of Avant-Garde Award for Medications Development

RADARS System Poison Center data can predict methadone overdose trends in the U.S.

Excess maternal iodine supplementation can lead to congenital hypothyroidism in infants

BD Hyflow needle essential for patient comfort and device integration

FDA grants priority review to GSK’s Promacta sNDA for treatment of thrombocytopenia

Fever in laboring women not associated with epidural analgesia

Study identifies 329 instances of potentially inappropriate prescribing in Irish older patients

Recent release: More effort needed to reach universal access to ART by 2015, MSF/UNAIDS report says

Drug resistance increasing in parts of Africa, report shows

New NIAID grant to support development of topical microbicide gel for HIV and HSV-2 infections

EC grants Marketing Authorisation to Boehringer Ingelheim and Lilly’s Jentadueto for diabetes

EMA COMP issues positive opinion to Albireo for A4250

Aeterna Zentaris files request with FDA for Fast Track designation for AEZS-130

Merck, Chimerix sign license agreement for CMX157 to treat HIV infection

Biokine receives FDA Orphan Drug designation for BKT140 to treat hematological cancers

Microneedles can deliver drug formulations into the eye

FDA approves 152 antiretroviral drugs in association with PEPFAR to treat HIV/AIDS

Mephedrone does have potential for abuse and addiction

New FDA guidelines on HIV And TB drug doses may not apply to African and Asian patients

Cost of HIV drugs cost less than previous thought, Clinton Foundation study says

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News